XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
CURRENT ASSETS    
    Cash and cash equivalents $ 406.0 $ 608.7
Restricted Cash 18.2 35.9
Short-Term Investments 220.0 0.0
    Accounts receivable, net 535.5 444.2
    Other current assets 162.9 117.8
Total current assets 1,342.6 1,206.6
PROPERTY AND EQUIPMENT, AT COST 1,087.1 957.0
    Less accumulated depreciation 133.5 66.1
Property, Plant and Equipment, Net, Total 953.6 890.9
Principal amount 246.9 249.1
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures 102.6 86.6
OTHER ASSETS 175.5 176.0
Total assets 2,821.2 2,609.2
CURRENT LIABILITIES    
Accounts payable - trade 256.6 225.8
Accrued liabilities and other 262.5 196.2
Total current liabilities 519.1 422.0
LONG-TERM DEBT 541.8 545.3
OTHER LIABILITIES 539.8 581.1
Total liabilities 1,600.7 1,548.4
Commitments and Contingencies
VALARIS SHAREHOLDERS' EQUITY    
Common shares, $0.01 par value, 700.0 shares authorized, 75.2 and 75.0 shares issued as of September 30, 2022 and December 31, 2021, respectively 0.8 0.8
Preference shares, $0.01 par value, 150.0 shares authorized, no shares issued as of September 30, 2022 and December 31, 2021 0.0 0.0
Stock warrants 16.4 16.4
Additional paid-in capital 1,092.0 1,083.0
Retained earnings (deficit) 114.3 (33.0)
Accumulated other comprehensive loss (9.1) (9.1)
Total Valaris shareholders' equity 1,214.4 1,058.1
NONCONTROLLING INTERESTS 6.1 2.7
Total equity 1,220.5 1,060.8
Total liabilities and shareholders' equity $ 2,821.2 $ 2,609.2